SCHEMBL3846446

SCHEMBL3846446

COc1ccc(-c2n[nH]cc2Br)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.49
PDE4B Q07343 5/20 0.49
PDE4C Q08493 4/20 0.49
PDE4D Q08499 4/20 0.49
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.46
KDM4E B2RXH2 5/20 0.45
HSD17B10 Q99714 1/20 0.45
PDE3B Q13370 1/20 0.43
PDE3A Q14432 1/20 0.43
MAPT P10636 2/20 0.43
GSK3B P49841 2/20 0.43
APP P05067 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
ADAM17 P78536 1/20 0.43
GAA P10253 1/20 0.43
MPI P34949 1/20 0.43
GFER P55789 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850635 0.77 MEN1 (0.51) ALDH1A1L3MBTL1KDM4EPDE3BPDE3A
SCHEMBL27912263 0.76 ALDH1A1 (0.50) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL16223030 0.76 LMNA (0.56) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL3846701 0.76 NOTUM (0.39) ALDH1A1MAPTTDP1
SCHEMBL17895374 0.75 GAA (0.50) ALDH1A1GAATDP1ADORA1CDK5
SCHEMBL28806715 0.73 TUBB4A (0.52) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL19806347 0.72 DAPK3 (0.43) PDE3BPDE3AGSK3BGSK3A
SCHEMBL8840880 0.71 PDE4A (0.67) PDE4AALDH1A1L3MBTL1KDM4EHSD17B10
SCHEMBL5756075 0.70 MAPT (0.45) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL13874329 0.70 MKNK1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed